ArticlePharmaceutics2023

Angiotensin II Receptor Blockers Reduce Tau/Aß42 Ratio: A Cerebrospinal Fluid Biomarkers' Case-Control Study.

Gemma García-Lluch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.